Showing results (121-130 of 2,329) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|June 5, 2013
The effect of moderate hepatic impairment on the pharmacokinetics of ipragliflozin, a novel sodium glucose co-transporter 2 (SGLT2) inhibitorWenhui Zhang, Walter J J Krauwinkel, James Keirns, et al.Clinical Drug Investigation|June 21, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat inhaled doses of umeclidinium in healthy subjects: two randomized studiesAnthony Cahn, Ruth Tal-Singer, Isabelle J Pouliquen, et al.Clinical Drug Investigation|May 8, 2012
Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetineAnjana Bose, Joyce Tsai, Dayong LiClinical Drug Investigation|October 2, 2013
Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucoseYing Han, Jun-Ping Shi, An-Lin Ma, et al.Clinical Drug Investigation|December 10, 2009
Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective studyMarta Ferrer, Mário Morais-Almeida, Margarita Guizova, et al.Clinical Drug Investigation|December 10, 2009
Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension studyMark S Kipnes, Eli M Roth, James M Rhyne, et al.Clinical Drug Investigation|November 1, 2017
Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort StudyAkiko Mizukami, Keiko Sato, Koichi Adachi, et al.Clinical Drug Investigation|November 3, 2017
Tofacitinib: A New Oral Therapy for PsoriasisAlexandra Azevedo, Tiago TorresClinical Drug Investigation|November 4, 2017
Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes MellitusNoboru Kurinami, Seigo Sugiyama, Hiroyuki Nishimura, et al.Clinical Drug Investigation|November 4, 2017
Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic PainEsther S KimPageof 233